ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 171 filers reported holding ANI PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $834,000 | -58.6% | 13,525 | -51.1% | 0.08% | -47.4% |
| Q3 2019 | $2,014,000 | -82.5% | 27,632 | -80.2% | 0.15% | -81.5% |
| Q2 2019 | $11,490,000 | +20.3% | 139,783 | +3.2% | 0.82% | +18.3% |
| Q1 2019 | $9,551,000 | -99.8% | 135,399 | +10.4% | 0.70% | +55.8% |
| Q4 2018 | $5,521,208,000 | +14.9% | 122,639 | +44.3% | 0.45% | +43.9% |
| Q3 2018 | $4,804,317,000 | -1.7% | 84,972 | +16.1% | 0.31% | -12.2% |
| Q2 2018 | $4,887,489,000 | +128.1% | 73,166 | +98.8% | 0.35% | +119.3% |
| Q1 2018 | $2,142,787,000 | +150.6% | 36,805 | +177.5% | 0.16% | +140.3% |
| Q4 2017 | $854,929,000 | +51.8% | 13,265 | +23.6% | 0.07% | +39.6% |
| Q3 2017 | $563,375,000 | +12.2% | 10,733 | 0.0% | 0.05% | +4.3% |
| Q2 2017 | $502,304,000 | -16.0% | 10,733 | -11.2% | 0.05% | -22.0% |
| Q1 2017 | $598,229,000 | – | 12,083 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
| Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
| Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
| 1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
| JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
| FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
| Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
| DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
| CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |